Kirn David's Form 4 filing
4D Molecular Therapeutics, Inc. (FDMT) · filed Jan 8, 2024
- Accession no.
- 0000950170-24-002945
- Filed
- Jan 8, 2024
- Trade date
- Dec 15, 2023-Jan 5, 2024
- Filing delay
- 24 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.96M. It was filed 24 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kirn DavidCIK 0001834021 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Common Stock | SSaleDisposed | −28,632 | $17.27 | −$494,474.64 | 1,230,521 | Direct | |
| Dec 18, 2023 | Common Stock | SSaleDisposed | −4,702 | $18.13 | −$85,247.26 | 1,225,819 | Direct | |
| Jan 4, 2024 | Common Stock | SSaleDisposed | −40,732 | $20.31 | −$827,266.92 | 1,185,087 | Direct | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −28,104 | $19.56 | −$549,714.24 | 1,156,983 | Direct | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −133 | $20.11 | −$2,674.63 | 1,156,850 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.